Transforming patient health through personalized, predictive care

Biofourmis utilizes machine learning, integrated biometric data and FDA-cleared analytics to streamline patient care.

98%

Patient Satisfaction Score

95%

Client Satisfaction Score

OUR AWARD-WINNING SOLUTIONS

iStock-1332650481

BIOFOURMIS CARE

Provide personalized care in the comfort of a patient’s home

Our simple to use platform enables clinical teams to remotely care for patients after discharge and between office visits with personalized treatment plans whether a patient has an acute or chronic need.

  • Improve clinical outcomes
  • Gain vital insights into patient health
  • Reduce costs and readmission rates

BIOFOURMIS DIGITAL MEDICINE

Real-world treatments for managing diseases and chronic conditions

Develop evidence-based digital therapies and patient adherence solutions aimed at early disease detection and personalization of care.

  • Advance clinical development
  • Enhance drug therapies
  • Improve patient outcomes
digitialmed

HOW WE ARE TRANSFORMING MEDICINE

Our innovative analytics engine, developed by 50+ data scientists, creates a personalized baseline for each patient. Each patient’s unique baseline is used to monitor their condition, and providers are only notified when clinically-relevant changes occur.  

We care for patients throughout the day — not just at select points — with continuous monitoring complemented by episodic data, patient-supplied insight and smart notifications that inform care teams of significant health changes.

With compatibility to 70+ wearables, customized patient questionnaires, and an integrated communication system to connect clinicians and patients, our platform can be accessed anywhere and utilized to treat patients across the care continuum.

We provide virtual and in-home support* to ensure that clinical, technical and logistical needs are covered by one partner. Our teams ensure your solution is not only deployed but understood throughout the implementation process.

*in certain geographic regions.

FDA
download
Skype_Picture_2022_04_25T16_21_49_403Z
Group 223

OUR AWARDS

Featured News & Resources

Biofourmis Raises Additional Funding from Intel Capital in Series D Extension and Names Top Healthcare Leaders to its Board

COMPANY NEWS

Biofourmis Raises Additional Funding from Intel Capital in Series D Extension and Names Top Healthcare Leaders to its Board

More
Appalachian Regional Healthcare Selects Biofourmis Tech for Home Hospital Programs, Including Rural Healthcare Study

COMPANY NEWS

Appalachian Regional Healthcare Selects Biofourmis Tech for Home Hospital Programs, Including Rural Healthcare Study

More
Wise Health System Partners with Biofourmis for Continuum-Wide Care-at-Home Initiative

COMPANY NEWS

Wise Health System Partners with Biofourmis for Continuum-Wide Care-at-Home Initiative

More

Trusted by leading health systems, payers, providers, biopharma companies, and patients

Better outcomes for all